1.
J. pediatr. (Rio J.)
;
92(5): 432-435, Sept.-Oct. 2016.
Article
in English
| LILACS
| ID: lil-796104
Subject(s)
Humans , Infant, Newborn , Vancomycin/standards , Vancomycin Resistance , Anti-Bacterial Agents/standards , Staphylococcal Infections/microbiology , Staphylococcal Infections/drug therapy , Staphylococcus , Vancomycin/therapeutic use , Intensive Care Units, Neonatal/standards , Coagulase , Neonatal Sepsis/drug therapy , Latin America , Anti-Bacterial Agents/therapeutic use
2.
Rev. Soc. Boliv. Pediatr
;
48(3): 176-177, 2009.
Article
in Spanish
| LILACS
| ID: lil-652509
ABSTRACT
La vancomicina frecuentemente es combinada con otros antimicrobianos debido a su deficiencia en el tratamiento de infecciones graves por Staphylococus aureus meticilino resistente (MRSA).